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Introduction
Ovarian metastases can account for as many as 30–40%
of all ovarian malignancies1–3. The potential for metas-
tatic tumors to mimic the clinical and morphologic
appearance of primary ovarian tumors is well known
to surgical pathologists2. Correct diagnosis and success-
ful management of patients with these diseases often
rely on the degree of distinction between primary and
metastatic tumors. Most of the recent literature empha-
sizes various origins for the tumors metastasizing to
malignant ovarian tumors. Ovarian metastatic tumors
originating from primary tumors in the gastrointes-
tinal tract are collectively known as the Krukenberg
tumors. The most common non-gynecologic primary
tumors are frequently observed in the large intestine1,4
or breast5,6. Cholangiocarcinoma or bile duct cancer
metastasizing to the ovary is extremely rare. It is read-
ily apparent that its retroperitoneal location and low
histologic specificity in the ovary often leads to a mis-
diagnosis. Limited clinical cases of this disease type
make any further attempt in the accurate diagnosis
based on clinical, radiologic and morphologic symp-
toms even more difficult. We present here a rare case of
a woman with recurrent cholangiocarcinoma, present-
ing as an ovarian Krukenberg tumor. It is hoped that
this case report can contribute to the understanding
of this unusual malignancy.
Case Report
A 61-year-old postmenopausal woman came to the
outpatient department of gastroenterology because of
abdominal distension and malaise for 1 month. Abdo-
minal examination revealed distension and a palpable
adnexal mass. Her past medical history indicated the
diagnosis of cholangiocarcinoma with mesocolic and
mesenteric metastases 2 years previously. She had re-
ceived surgery and 15 courses of 5-fluorouracil and leu-
covorin as postoperative adjuvant chemotherapy until
10 months previously, followed by oral uracil-tegafur
until presentation. Initial laboratory studies did not
reveal abnormal findings, except elevation of tumor
markers (CA-125 assay was 546.4U/mL). She was referred
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to the outpatient department of gynecology for further
evaluation after computed tomography of the abdomen
showed a pelvic mass and massive ascites (Figure 1).
Ultrasound examination revealed a complex cystic
mass, measuring about 9×10 cm in size with septum,
and power Doppler blood flow (resistance index, 0.4;
Figure 2). Exploratory laparotomy revealed a bilateral
ovarian tumor measuring 10×9 cm and 6×4 cm for the
right and left ovarian tumors, respectively, and intra-
peritoneal tumor implants. Bloody ascites of 2,000mL in
the abdominal cavity were also noted and sampled for
cytologic examination. A surgical specimen of the ova-
ries indicated metastatic adenocarcinoma upon frozen
section analysis. Bilateral salpingo-oophorectomy and
partial omentectomy were performed, and the associ-
ated pathology report was consistent with a diagnosis
of metastatic adenocarcinoma compatible with cholan-
giocarcinoma. No further adjuvant treatment was car-
ried out postoperatively as a result of rapid progression
of carcinomatosis and intestinal obstruction. She died
5 months after operation.
Discussion
We present here a rare case of a woman with cholan-
giocarcinoma, manifested as a pelvic mass as the result
of ovarian metastasis. The exceptional rarity of ovarian
metastatic tumors of bile duct origin in the literature
initially led us to regard this case as a primary ovarian
tumor. Being an unlikely and unfamiliar ovarian metas-
tasis, the possibility of cholangiocarcinoma was pre-
cluded from our initial clinical diagnosis. The ovarian
gross appearance was similar to those of primary ovar-
ian tumors. However, in conjunction with the patient’s
past medical history of cholangiocarcinoma, the pre-
sentation of bilateral ovarian tumors and the frozen
section analysis of the resected specimen allowed us
to conclude that this was metastatic adenocarcinoma
of the ovary. Metastatic tumors of the ovary often ren-
der clinical confusion in diagnosis of primary ovarian
tumors5,7. An important clue that differentiates primary
tumors from metastatic tumors is bilaterality. Fewer
than 10% of primary ovarian neoplasms are bilateral7,
and unilateral involvement of the ovarian metastases
can be a good indication of primary ovarian cancer. 
A further classification has successfully subcategorized
unilateral involvement with tumor sizes of less than
10 cm as metastatic, and those of more than 10 cm as
primary ovarian cancers8. Other predominant features
of metastatic tumors often involve the presence of signet
ring cells, surface involvement by tumor cells, and ex-
tensive extraovarian tumor, whereas features of primary
ovarian neoplasms include smooth external surfaces
as well as a complex papillary pattern7. The manage-
ment of patients with Krukenberg tumors after gastric
cancer by metastasectomy has been shown to reveal
significant improvement in overall and progression-
free survival9–12. However, performing metastasectomy
did not seem to improve the management of the
patient with recurrent cholangiocarcinoma presenting
as an ovarian Krukenberg tumor in this clinical case
Figure 1. A heterogeneously enhancing mass in the lower
pelvic region.
Figure 2. Complex cystic mass of 9×10 cm in size with septum
and power Doppler blood flow (resistance index, 0.4).
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report. We believe that a combination of cautious clini-
cal evaluation and pathologic examination that allows
us to better differentiate metastatic adenocarcinoma
from primary ovarian carcinoma at diagnosis is ex-
tremely important. Further studies are required to char-
acterize and improve the outcome of this rare disease.
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